title: Adjuvant treatment of postmenopausal patients with high risk primary breast cancer. Results from the Danish adjuvant trials DBCG 77 C and DBCG 82 C.
abstract: The efficacy of adjuvant treatment with tamoxifen was evaluated in protocol DBCG 77 C. Postmenopausal high risk patients (tumor greater than 5 cm, positive axillary nodes, or invasion to skin/fascia) were randomized after total mastectomy and axillary sampling to postoperative radiotherapy (control) or to radiotherapy plus treatment with tamoxifen (TAM), 30 mg daily for 1 year. A total of 1,716 patients entered the study. At 8 years of follow-up, (7 years median time of observation), we observed a significant increase of recurrence-free survival for the TAM treated group and a reduction in mortality, which is significant for patients less than 70 years of age. Retrospectively, an increased recurrence-free survival in TAM treated patients was significant in the following subgroups: tumor less than 5 cm, positive lymph nodes, anaplasia grade II and estrogen receptor level greater than 100 fmol/mg cytosol protein. In the subsequent trial (DBCG 82 C), 1,347 postmenopausal patients less than 70 years were randomized to one of the following 3 regimens: radiotherapy + tamoxifen, 30 mg daily for 1 year (TAM), TAM alone, or TAM + CMF (CMF i.v. day 1 every 4 weeks x 9). The survival is similar in the 3 groups at 4 years (2 years median time of observation).
authors.affiliation: Department of Oncology ONA, Finsen Institute, Rigshospitalet, Copenhagen, Denmark.
authors.forename: H T
authors.initials: HT
authors.lastname: Mouridsen
authors.forename: C
authors.initials: C
authors.lastname: Rose
authors.forename: M
authors.initials: M
authors.lastname: Overgaard
authors.forename: P
authors.initials: P
authors.lastname: Dombernowsky
authors.forename: J
authors.initials: J
authors.lastname: Panduro
authors.forename: S
authors.initials: S
authors.lastname: Thorpe
authors.forename: B B
authors.initials: BB
authors.lastname: Rasmussen
authors.forename: M
authors.initials: M
authors.lastname: Blichert-Toft
authors.forename: K W
authors.initials: KW
authors.lastname: Andersen
mesh_terms: D000368:Aged; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000532:radiotherapy / Q000601:surgery; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D015413:Mastectomy, Simple; D008593:Menopause; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local; D011897:Random Allocation; D012307:Risk Factors; D013629:Tamoxifen / Q000627:therapeutic use*
chemical_list: D013629:Tamoxifen